Comment on: "Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial"

被引：0
|
作者：
Cengiz, M [1 ]
Selek, U [1 ]
Yildiz, F [1 ]
Sari, S [1 ]
机构：
[1] Hacettepe Univ, Fac Med, Dept Radiat Oncol, TR-06100 Ankara, Turkey
来源：
RADIOTHERAPY AND ONCOLOGY | 2005年 / 74卷 / 01期
关键词：
D O I：
10.1016/j.radonc.2004.11.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [41] Adjuvant therapy for locally advanced non-small cell lung cancer
    Keller, SM
    LUNG CANCER, 2003, 42 : S29 - S34
  • [42] Proton therapy for locally advanced non-small cell lung cancer
    Gjyshi, Olsi
    Liao, Zhongxing
    BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1107):
  • [43] Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: Results of Eastern Cooperative Oncology Group 4593
    Mehta, MP
    Tannehill, SP
    Adak, S
    Martin, L
    Petereit, DG
    Wagner, H
    Fowler, JF
    Johnson, D
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) : 3518 - 3523
  • [44] Concurrent Chemo-Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer
    Kim, Jin Hee
    Kim, Ok Bae
    Byun, Sang Jun
    Park, Seung Gyu
    Oh, Young Kee
    Choi, Tae Jin
    Jeon, Young June
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S415 - S415
  • [45] Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer
    Choy, H
    Akerley, W
    DeVore, RF
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 36 - 43
  • [46] Dose-Escalated Radiation Therapy with a Simultaneous Integrated Boost with or without Adjuvant Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer
    Jahshan, A.
    Quinn, T. J.
    Johnson, M. C.
    Mankuzhy, N.
    Almahariq, M. F.
    Barski, M.
    Ye, H.
    Guerrero, T. M.
    Stevens, C. W.
    Grills, I. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E95 - E95
  • [47] Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial
    Brade, Anthony M.
    Wenz, Frederik
    Koppe, Friederike
    Lievens, Yolande
    San Antonio, Belen
    Iscoe, Neill A.
    Hossain, Anwar
    Chouaki, Nadia
    Senan, Suresh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (04): : 927 - 934
  • [48] Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
    Eager, R. M.
    Cunningham, C. C.
    Senzer, N.
    Richards, D. A.
    Raju, R. N.
    Jones, B.
    Uprichard, M.
    Nemunaitis, J.
    CLINICAL ONCOLOGY, 2009, 21 (06) : 464 - 472
  • [49] Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer
    Price, Katharine A.
    Azzoli, Christopher G.
    Krug, Lee M.
    Pietanza, Maria C.
    Rizvi, Naiyer A.
    Pao, William
    Kris, Mark G.
    Riely, Gregory J.
    Heelan, Robert T.
    Arcila, Maria E.
    Miller, Vincent A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1623 - 1629
  • [50] Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC)
    Hansen, O.
    Knap, M.
    Khalil, A.
    Nyhus, C.
    Brink, C.
    Hoffmann, L.
    Schytte, T.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S663 - S663
12345